Candida Species Prevalence Profile in HIV Seropositive Patients from a Major Tertiary Care Hospital in New Delhi, India

Table 3

Immunological profile of study subjects. .

		Number	Percentage
CD4 count (cells/µL)	0–50	6	5%
	51–100	14	12%
	101–200	26	22%
	201–300	28	23%
	301–400	32	27%
	401–500	6	5%
	>500	8	7%
		Mean (standard deviation)	95% confidence interval	value
Mean CD4 counts in relation to the presenting complaints (cells/µL)	Single complaint	318 (86)	176 to 389	0.0004
	Double complaint	272.1 (118)	202 to 344	0.0001
	Three complaints	223 (107)	179 to 268	0.0001
	Four complaints	136 (94)	21 to 251	0.0045
	Five complaints	49 (22)	21 to 109
		Mean (standard deviation)	95% confidence interval	value
Mean CD4 counts in relation to the presence of Candida infection (cells/µL)	Subjects with Candida infection	142.6 (72)	68 to 201	0.0001
	Subjects without Candida infection	412.3 (93)	189 to 516
		Mean (standard deviation)	95% confidence interval	value
Mean CD4 counts in relation to WHO clinical stage (cells/µL)	Stage I	407.8 (114)	312 to 502	0.0001
	Stage II	308.2 (98)	218 to 489	0.0001
	Stage III	190.7 (92)	95 to 263	0.0001
	Stage IV	96.1 (45)	35 to 116